One Stop Solution Partner

One Partner,
Full Journey.

INCREASE provides integrated, end-to-end services that support healthcare innovations from research and development through to market access. Combining contract research organization (CRO) services, central laboratory capabilities, and regulatory expertise under one platform, INCREASE simplifies the development journey and reduces the complexity of managing multiple partners.

The full journey

From ideation to market access.

  1. Study Design
  2. Site Activation
  3. Trial Execution
  4. Data Management
  5. Market Access

End-to-end Capabilities

Study
Design

  • Protocol aligned with lab & regulatory
  • Feasibility based on real site data
  • Regulatory strategy tailored to BPOM & regional requirements
1
Study Design01
2
Site Activation
3
Trial Execution
4
Data Management
5
Market Access

End-to-end Capabilities

Site
Activation

  • Parallel regulatory & site activation
  • Pre-qualified network of clinical sites
  • Ethics & regulatory submission processed simultaneously
Study Design
2
Site Activation02
3
Trial Execution
4
Data Management
5
Market Access

End-to-end Capabilities

Trial
Execution

  • Patient recruitment & site management
  • Integrated CRO–lab coordination
  • Centralized in-house sample management
Study Design
Site Activation
3
Trial Execution03
4
Data Management
5
Market Access

End-to-end Capabilities

Data
Management

  • Samples, laboratory results, and study documentation in one system.
  • No third-party handover, no reconciliation between vendors.
  • Unified, submission-ready dataset.
  • Real-time data quality monitoring.
Study Design
Site Activation
Trial Execution
4
Data Management04
5
Market Access

End-to-end Capabilities

Market
Access

  • Regulatory submission support
  • With CRO, laboratory, and data systems under one roof, submission packages come together faster and reach BPOM without waiting on external handovers
  • Post-approval monitoring & lifecycle management
Study Design
Site Activation
Trial Execution
Data Management
5
Market Access05

Why we win

Integration Drives
Better Outcomes

Traditional Model
  • Multiple vendors
  • Fragmented data
  • Risky international sample transport
  • Misaligned execution
INCREASE Model
  • Single partner
  • Unified data flow
  • Eliminates dependency on international sample transport
  • End-to-end coordinated execution across CRO, lab, and regulatory

Better data · Faster timeline · Lower risk

Speed advantage

Faster
Study

Normal

6–9

months

50%

INCREASE

3–6

months

  • Early laboratory integration
  • Sequential → parallel execution
  • Investigator and site network ready
  • Expert regulatory team
  • Integrated study documentation
  • Centralized project management
  • Dedicated team with subject-matter experts in each field
  • End-to-end services tailored to client needs
  • Site and regional coverage across Indonesia

*Based on internal project benchmark. Actual timelines are estimates and may vary depending on study complexity and project requirements.

Our People

The People Behind INCREASE

From clinical research experts to regulatory specialists, our team is structured to deliver integrated solutions — from study design to market access.

Meet the full team

dr. Robby Hertanto

Chief Executive Officer

Apt. David Chen, PhD

Head of Finance, Accounting and Tax

Yuyus Kusnadi, PhD

Head of Clinical Operations

Apt. Rizki Tsari Andriani, PhD

Head of Laboratory Operations

Ns. Agus Gunadi (Nadi), M.Epid.

Clinical Project Manager

Heny Purwanti, M.Sc

Bio-analytical Lab Manager

The INCREASE team

Vision Mission  |  Core Values  |  Quality Policy

Company Values